Previous studies suggest that elevated AIP reflects insulin resistance, dyslipidemia, and proinflammatory metabolic states, which promote endothelial dysfunction and atherogenesis, thereby increasing the likelihood of plaque vulnerability [47,48,49,50,51]. The gene discussed is AIP; the disease is metabolic syndrome.